Funding in, findings out
For any dataset: the NCI award that paid to create it, and the awards that got a published finding out of it afterwards.
msk_chord_2024
MSK-CHORD (MSK, Nature 2024)
10 awards paid to create it · 0 awards funded work that used it
1. Awards that paid to create this data (6 of 10)
- Automatic integrated biomarkers to improve prediction of lung cancer outcomes · Justin Jee · FY2024–2026
- MSK Paul Calabresi Career Development Award for Clinical Oncology · Omar Abdel-Wahab, Simon N. Powell · FY2015–2026
- Administrative Core · PHILIP W KANTOFF, CHARLES L. SAWYERS · FY2019–2024
- Core B: Molecular Pathology and Bioinformatics Core · Michael F. Berger, Deborah Schrag · FY2025–2026
- Antitumor Assessment · Elisa de Stanchina, FRANCESCA M GANY · FY2025–2026
- SPORE in Prostate Cancer · Yu Chen, MICHAEL J MORRIS · FY2025–2026
The best connected are shown.
2. The dataset
3. Articles that used it
4. Awards those articles were funded by
Why one side of this chain is empty
- This dataset has no accession that articles quote, so no reuse can be traced and nothing it enabled is visible.
Awards that paid to create this data
Credited on the dataset's own marker paper.
| Award | Project | Evidence |
|---|---|---|
| K08CA286842 K08FY2024–2026$769k | Automatic integrated biomarkers to improve prediction of lung cancer outcomes | API |
| K12CA184746 K12FY2015–2026$8.3M | MSK Paul Calabresi Career Development Award for Clinical Oncology | API |
| P01CA228696 P01FY2019–2024$17.3M | Administrative Core | API |
| P01CA275746 P01FY2025–2026$9.2M | Core B: Molecular Pathology and Bioinformatics Core | API |
| P30CA008748 P30FY2025–2026$48.4M | Antitumor Assessment | API |
| P50CA092629 P50FY2025–2026$5.2M | SPORE in Prostate Cancer | API |
| R01CA217169 R01FY2018–2022$2.5M | BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma | API |
| R01CA234361 R01FY2019–2023$2.0M | Defining mechanisms of resistance to hormonal therapy in breast cancer | API |
| R01CA240472 R01FY2019–2023$2.4M | Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma | API |
| T32CA009207 T32FY1985–2026$20.1M | Investigational Cancer Therapeutics Training Program (ICTTP) | API |
Where the links come from
NIH RePORTER maps a PMID to the awards that reported it. On a dataset’s marker paper that gives the awards which created it; on an article that used the data, the awards which funded that use.
The two sides are not measured alike. Generation is complete: a dataset has one marker paper and every award on it is resolved. Reuse is a sample - the articles using a dataset can number in the thousands, and only the few dozen strongest are retrieved and looked up. Every award shown here funded reuse; there are more that are not shown.
How far it reaches
283 datasets have an award credited with creating them, 80 with using them, and 31 both.
What is missing
No citable accession means no traceable articles; no authoritative marker paper means no attributable generation award. Absence is a gap in the record. Methods.
Start from an award instead, and see every dataset it touches.